id:"swepub:oai:lup.lub.lu.se:94b3a0ac-b57b-4f7c-90b0-78338e3d9b86"
Sökning: id:"swepub:oai:lup.lub.lu.se:94b3a0ac-b57b-4f7c-90b0-78338e3d9b86" > Comparison of the A...
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer : a multicentre external validation in patients who underwent surgery
-
- Landolfo, Chiara (författare)
- Queen Charlotte's and Chelsea Hospital,Catholic University of Leuven,Policlinico Universitario Agostino Gemelli
-
- Ceusters, Jolien (författare)
- Catholic University of Leuven
-
- Valentin, Lil (författare)
- Lund University,Lunds universitet,Obstetrisk, gynekologisk och prenatal ultraljudsdiagnostik,Forskargrupper vid Lunds universitet,Obstetric, Gynaecological and Prenatal Ultrasound Research,Lund University Research Groups,Skåne University Hospital
- visa fler...
- visa färre...
- (creator_code:org_t)
- Engelska.
- Ingår i: British Journal of Cancer. - 0007-0920.
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- Background: Several diagnostic prediction models to help clinicians discriminate between benign and malignant adnexal masses are available. This study is a head-to-head comparison of the performance of the Assessment of Different NEoplasias in the adneXa (ADNEX) model with that of the Risk of Ovarian Malignancy Algorithm (ROMA). Methods: This is a retrospective study based on prospectively included consecutive women with an adnexal tumour scheduled for surgery at five oncology centres and one non-oncology centre in four countries between 2015 and 2019. The reference standard was histology. Model performance for ADNEX and ROMA was evaluated regarding discrimination, calibration, and clinical utility. Results: The primary analysis included 894 patients, of whom 434 (49%) had a malignant tumour. The area under the receiver operating characteristic curve (AUC) was 0.92 (95% CI 0.88–0.95) for ADNEX with CA125, 0.90 (0.84–0.94) for ADNEX without CA125, and 0.85 (0.80–0.89) for ROMA. ROMA, and to a lesser extent ADNEX, underestimated the risk of malignancy. Clinical utility was highest for ADNEX. ROMA had no clinical utility at decision thresholds <27%. Conclusions: ADNEX had better ability to discriminate between benign and malignant adnexal tumours and higher clinical utility than ROMA. Clinical trial registration: clinicaltrials.gov NCT01698632 and NCT02847832.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
- British Journal of Cancer (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Landolfo, Chiara
- Ceusters, Jolien
- Valentin, Lil
- Froyman, Wouter
- Van Gorp, Toon
- Heremans, Ruben
- visa fler...
- Baert, Thaïs
- Wouters, Roxanne
- Vankerckhoven, A ...
- Van Rompuy, Anne ...
- Billen, Jaak
- Moro, Francesca
- Mascilini, Flori ...
- Neumann, Adam
- Van Holsbeke, Ca ...
- Chiappa, Valenti ...
- Bourne, Tom
- Fischerova, Dani ...
- Testa, Antonia
- Coosemans, An
- Timmerman, Dirk
- Van Calster, Ben
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Reproduktionsmed ...
- Artiklar i publikationen
- British Journal ...
- Av lärosätet
- Lunds universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
